University of Iowa Diagnostic Laboratories (UIDL) | Carver College of Medicine

University of Iowa Diagnostic Laboratories

The standard for testing excellence.

UIDL is dedicated to providing excellence in laboratory testing and improving the quality of patient care provided by the physician offices, hospitals, laboratories, and medical facilities we serve.

Faculty and Services Test Directory Supply and Kit Orders

About University of Iowa Diagnostic Laboratories

UIDL, affiliated with UI Health Care, is a national reference laboratory offering academic expertise in specialty anatomic pathology services, advanced molecular genetic testing, and rapid renal biopsy consults. We offer very competitive turnarounds. All pathologists are available for immediate consultation by phone or email.

All of our pathologists are academic and hold professional appointments in the University of Iowa Department of Pathology, Carver College of Medicine. Each is involved in daily patient care as well as teaching in a renowned residency program and strong medical school.

Our established culture of excellent patient care is our prime objective. Emphasis is placed on practical solutions for specimen workups. The most expedient and sure method of diagnosis is utilized ensuring high quality yet cost-effective patient care.

Learn more about us

Client Portal

Find information about test ordering, results, payments and other communication and coordinated care services for referring providers.

Various lab test packaging supplies, including boxes and envelopes

Supply Ordering for Clients

Order supplies necessary for the transport of specimens to UIDL for analysis: available to all clients. Please click the button below to begin placing your order.

# 1

Ranked Hospital in Iowa

2.5 m

Tests performed per year

Boyd Tower with colorful trees in front of it

500 +

Tests Available

Support and Assistance

Reach out to UIDL if you have questions or concerns. We're here to help!

Support

Test Directory

Browse UIDL's test directory, containing over 500 tests.

Sending a case

Learn about various topics related to sending cases to UIDL

News

Dr. John Harty Receives Two-Year R21 Research Grant from the National Institutes of Health Investigating the Impact of Brain Residing T Cells on the Function of Brain Resident Microglia and Dendritic Cells

Monday, June 17, 2024

Dr. Harty received a new 2 year grant from the NIH entitled “Brain T cell interactions in microbial experienced mice.” The award totals $404,300, the project started June 4, 2024 and concludes April 30, 2026.

Genetic Factors can Increase the Risk of a Toxic Reaction to Certain Cancer Drugs

Monday, May 6, 2024

Cancer researcher Steven Offer, PhD investigates the genetic factors that increase the risk of a toxic reaction to the cancer drug Fluorouracil (5-FU). 5-FU, used since the 1970s to treat many cancers including colorectal, stomach, breast and cervical cancer, can be toxic to certain patients. While many cancer drugs can be toxic, what sets 5-FU apart is that severe illness and death is largely preventable.

Recent Publications

Week of July 23, 2024
Predictors of Postpartum Hemorrhage and Associated Outcomes at a Midwest Academic Medical Center. Mooberry M, Voss N, Wendt L, Kenne KA, Jackson JB, Rysavy MB. Womens Health Rep (New Rochelle). 2024 Apr 26;5(1):358-366. doi: 10.1089/whr.2023.0192. eCollection 2024.

Clinical implication of PRAME immunohistochemistry in differentiating melanoma in situ and dysplastic nevus in non-acral nevus-associated melanoma in situ: An institutional experience and meta-analysis. Bui CM, Vuong HG, Le MK, D'Angelo J, Mannava K, Smoller BR. J Cutan Pathol. 2024 Jun 21. doi: 10.1111/cup.14671. Online ahead of print.

Structural disruption of Ntox15 nuclease effector domains by immunity proteins protects against type VI secretion system intoxication in Bacteroidales. Bosch DE, Abbasian R, Parajuli B, Peterson SB, Mougous JD. mBio. 2023 Aug 31;14(4):e0103923. doi: 10.1128/mbio.01039-23. Epub 2023 Jun 22.